Immuron Limited (NASDAQ: IMRN)

(10:47)

Immuron Limited (NASDAQ: IMRN)

(10:18)

Immuron Limited (NASDAQ: IMRN)

(24:26)

Immuron Ltd. (NASDAQ: IMRN | ASX: IMC): Virtual Investor Conferences

(33:41)

Sequire Spotlight Presents Immuron Limited (IMRN): Creating New Products for Infectious Diseases

(7:6)

Targeted Polyclonal Antibodies | Immuron Ltd (NASDAQ: IMRN) | GCFF Virtual 2024 Bio Investing

(20:42)

Immuron Limited (NASDAQ: IMRN)

(12:30)

Immuron Limited (ASX: IMC) (NASDAQ: IMRN)

(22:51)

Immuron Ltd - TechKnow Invest Roadshow 2024

(14:21)

Immuron Limited (NASDAQ: IMRN)

(10:5)

Immuron working towards US FDA approval of Traveler’s Diarrhea product Travelan

(6:24)

Immuron (ASX:IMC / NASDAQ:IMRN) Investor Presentation - Business Update (19 April 2023)

(15:15)

Immuron (ASX:IMC / NASDAQ:IMRN) Investor Presentation - Business Update (February 28 2023)

(21:5)

Immuron on How their Gastrointestinal and Digestive Health Immune Supplements Work + FY23 Sales

(10:28)

Just the Facts: Immuron

(1:44)

Immuron Ltd Investor Presentation - FY22 Results \u0026 Business Update

(31:29)

Immuron Ltd CEO Steve Lydeamore At The JustStocks Investor Events 2024

(21:55)

Bloomberg Turnaround: AstraZeneca

(24:7)

Coach Declares the BMS Team is Now Celibate | Blue Mountain State

(4:37)

Sanofi CEO on AI's Impact, Lung Disease Drug Clearance

(8:54)

Immuron welcomes launch of Travelan on Amazon US

(3:30)

Immuron (ASX:IMC): Developing \u0026 commercialising a novel class of targeted polyclonal antibodies

(4:)